Arjo is making a second issue under its MTN program. Read more.
CellaVision reports weaker quarters with varying developments in the regions. Read more.
FluoGuide strengthens its leadership to drive the clinical program and regulatory approval strategy forward. Read more.
Hamlet BioPharma confirms its strategy for non-antibiotic treatment of infections through a clinical study in infants. Read more.
iZafe publishes monthly newsletter for October describing growth, integration and international expansion. Read more.
Nightingale Health enters into a partnership with Alamar Biosciences to expand its unique multiomics offering with ultra-sensitive proteomics for brain health. Read more.
Novo Nordisk reports that Wegovy users achieved waist and BMI goals linked to improved health and a low risk of obesity-related complications. Read more.
Prolight Diagnostics publishes investor letter for November 2025. Read more.
Realheart receives patent approvals in key Asian markets. Read more.
Reputable healthcare provider in Canada implements Sects cloud service for better patient care. Read more.
Thor Medical and Telix Pharmaceuticals signs strategic supply agreement for thorium-228. Read more.
Insider trading & whistleblowing
Invitations & presentations
Alligator Bioscience Cantargia Genmab Hansa Biopharma Lifecare Mendus oculis Perpetua Medical SOBI
Communiqués
Summons
Reports
Acarix Active Biotech ArcticZymes Technologies Asker AstraZeneca Camurus CellaVision ContextVision Medivir Mentice Nanexa Optomed Peptonic Medical
Nomination committees
The latest from BioStock
» Vesper Bio reports promising results in Phase Ib/IIa
» Pila Pharma stands out in next-generation obesity pipeline
» Enzymatica’s CEO steps down after four years – summarizes a journey from science to commercialization
» Sound Bioventures invests SEK 34 million in Boost Pharma
» Kimberly-Clark and Kenvue merge in multi-billion dollar deal